Premium
Modular Assembly of Allosteric MEK Inhibitor Structural Elements Unravels Potency and Feedback‐Modulation Handles
Author(s) -
Hartung Ingo V.,
Pühler Florian,
Neuhaus Roland,
Scholz Arne,
Siemeister Gerhard,
Geisler Jens,
Hillig Roman C.,
von Ahsen Oliver,
Hitchcock Marion
Publication year - 2015
Publication title -
chemmedchem
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.817
H-Index - 100
eISSN - 1860-7187
pISSN - 1860-7179
DOI - 10.1002/cmdc.201500442
Subject(s) - allosteric regulation , modular design , potency , chemistry , modulation (music) , biophysics , nanotechnology , stereochemistry , computer science , biochemistry , materials science , biology , receptor , physics , in vitro , acoustics , operating system
Having recently identified a so‐far unexplored area adjacent to the known binding site of allosteric mitogen‐activated protein kinase kinase (MEK) inhibitors, we now report an extension of these studies by combining our new side chains with different MEK inhibitor cores in a modular manner. Replacement of the amide headgroup with inverse sulfonamides resulted in the identification of new MEK inhibitors with at least 10‐fold higher cellular potency against K‐Ras‐mutated tumor cells. A selected inhibitor from this new series retained the favorable pharmacokinetic profile of its predecessor in rodent and non‐rodent species and displayed significant in vivo efficacy at once‐daily oral doses of 0.25–1 mg kg −1 in a K‐Ras‐mutated xenograft model. The brain penetration potential of this analogue was significantly attenuated relative to PD325901. In a second series, the central fluorophenyl core was replaced by a pyridine moiety which gave rise to a similar boost in cellular potency. Most notably, analogues from this second series do not show MEK feedback phosphorylation in K‐Ras‐mutated A549 cells. Our results complement recent reports on the structural intricacies of MEK–Raf feedback interactions.